FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
Triplet combination treatment shows 51 percent reduction in the risk for death and tripled median progression-free survival versus a daratumumab-based triplet
Gene Expression Profile Test IDs Patients Who Can Skip SLNB in Melanoma
Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive
Lower Eosinophil Count Linked to Mortality in Patients With Acute COPD Exacerbation in ICU
Researcher says incorporating eosinophil counts into ICU triage or management protocols may help identify high-risk patients more accurately
COVID Vaccine Before ICI Initiation Tied to Increased Survival in Patients With Cancer
SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma
Low Placental Growth Factor Predicts Early-Onset Preeclampsia in Patients With SCD
PlGF cutoff <100 pg/mL demonstrated 100 percent sensitivity and specificity at 20 to 24 weeks of gestation for early-onset preeclampsia
Pazopanib Well-Tolerated in Young With Primary Multimetastatic Ewing Sarcoma
No significant toxicities observed in 11 patients included in study; 10 were alive at median follow-up of 2.6 years
Medicaid Expansion Tied to Smaller Declines in Early-Stage Cancer Detection
Smaller declines seen in early-stage cancer diagnosis during COVID-19 pandemic in adults aged 18 to 44 years, men, those with high comorbidity burden
Macrovascular Infiltration May Predict Cancer Mortality
Spikes in circulating tumor cell clusters identified immediately preceding death
Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma
Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant
Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
15.8 percent lower risk for death seen with abemaciclib-ET versus ET in intent-to-treat population
